Abbott Laboratories stock gains 2.98 percent amid #WeGiveBlood competition announcement, AbbottNews says

Traders Union
All News
Business & Wealth
Companies
Abbott Laboratories rises 2.98% today

Highlights

Abbott Laboratories rallied 4.43% for the week to $107.60, consolidating just below strong long-term resistance.
Technical momentum remains bullish in the short and medium term, with multiple indicators signaling an overbought market near weekly highs.
Forecast expects consolidation between $104.00 and $110.50, with a heightened risk of short-term pullback and limited chance of further upside breakout.

The company encouraged people to get ready to donate blood and referenced rolling up sleeves for the event. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term bullish structure as long-term resistance caps upside

Abbott Laboratories (ABT) is trading at $107.60, positioning firmly above the MA-20 ($96.31) and MA-50 ($91.69), but still slightly below the MA-200 ($108.87). This structure signals strong short- and medium-term bullish momentum, while long-term resistance remains overhead. The Ichimoku Kijun on D1 is at $96.51, which sits well below the current price and now serves as immediate support. Near-term support is identified at $96.31 (MA-20) and then $91.69 (MA-50), while near-term resistance is set at $108.87 (MA-200), with key resistance further up at $95.54 (MA-100) and strong support reinforced at $96.51 (Kijun).

Overbought momentum conditions as price rallies to weekly highs

Momentum readings from D1 MACD and ADX both point to ongoing bullish strength, while the RSI is elevated at 69.93, and CCI, Stoch RSI, and BBP all indicate a strongly overbought market with persistent buyer dominance. The Awesome Oscillator also confirms the upward momentum. In today's session, ABT has gained 2.98%, breaking out to the very top of its weekly range. Over the past week, ABT is trading at $107.60, up from a previous weekly close of $103.10, reflecting a 4.43% gain as the stock tests weekly highs. Weekly volatility stands at 6.03%. The price action shows a strong rally with consolidation at resistance.

Limited upside probability as bearish trend contains breakout potential

For the coming week, the expected price range for ABT is $104.00 to $110.50, keeping the forecast within 5–7% of the current price and referencing a year-to-date band between the $81.97 low and $137.49 high. Probability modeling based on weekly indicators suggests a very low probability (less than 20%) of further upside, with a higher likelihood of a short-term pullback or sideways movement. The baseline scenario sees ABT consolidating within a narrow band below major resistance. A bullish breakout above $108.87 could trigger a run toward $110.50 if momentum persists. Conversely, a bearish breakdown below $104.00 would expose the stock to deeper retracement toward the $100–$102 region. Overall, the year-to-date trend remains bearish, limiting the prospect of a sustained upside despite the current short-term strength.

Earlier, analysts noted that Abbott Laboratories was displaying short- and medium-term bullish momentum, even as long-term resistance remained a challenge. In the current context, investors should closely watch for any breakout above recent consolidation, as this could signal a new directional move for the stock.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.